Development and validation of a radiomics model for detecting cardiac amyloidosis at coronary computed tomography

Qingchao Meng1, Li Zhao1, Xiaoxin Sun2

  • 1Department of Radiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College/National Center for Cardiovascular Diseases, #167 Bei-Li-Shi Street, Beijing 100037, China.

Insights

Computed tomography (CT)-based radiomics effectively detects cardiac amyloidosis (CA) in patients with diffuse myocardial thickening. This radiomics model significantly outperformed standard CT attenuation measurements for CA diagnosis.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Cardiac amyloidosis (CA) is a significant cause of heart failure.
  • Diffuse myocardial thickening is a common presentation of CA.
  • Accurate and early diagnosis of CA is crucial for patient management.

Purpose of the Study:

  • To evaluate the diagnostic performance of computed tomography (CT)-based radiomics for detecting cardiac amyloidosis (CA).
  • To compare the efficacy of a radiomics model against standard myocardial CT attenuation measurements in patients with diffuse myocardial thickening.

Main Methods:

  • Retrospective enrollment of 378 patients with diffuse myocardial thickening from five hospitals.
  • Development of a radiomics model using features extracted from myocardial regions of interest.
  • Comparison of the radiomics model's diagnostic performance with myocardial CT attenuation using area under the curve and decision curve analysis.

Main Results:

  • The radiomics model demonstrated significantly higher diagnostic accuracy than myocardial CT attenuation across training, internal, and external test cohorts (AUCs 0.95, 0.95, and 0.91 vs. 0.58, 0.59, and 0.64, respectively).
  • Decision curve analysis confirmed the superior clinical utility of the radiomics model.
  • Radiomics scores showed significant correlations with N-terminal proB-type natriuretic peptide and left ventricular diastolic diameter.

Conclusions:

  • A CT-based radiomics model shows excellent diagnostic performance for cardiac amyloidosis in patients with hypertrophic phenotypes.
  • The radiomics approach significantly outperforms traditional myocardial CT attenuation measurements for CA detection.
Abstract